|
|
Vaccine Comparison
|
Infanrix -IPV/Hib |
| Vaccine Information |
- Vaccine Name: Infanrix -IPV/Hib
- Product Name: Diphtheria, tetanus, pertussis (acellular component), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed)
- Tradename: Infanrix -IPV/Hib
- Manufacturer: GlaxoSmithKline
- Vaccine Ontology ID: VO_0010722
- CDC CVX code: 120
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B Neomycin , Latex in plunger stopper of prefilled syringe
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store in a refrigerator (2°C – 8°C).
- Approved Age for Licensed Use: 2 months to 6 years of age.
- Description: Products: Proteins + killed virus + conjugate. Other components: Formaldehyde Polysorbate 80, Lactose.
|
| References |
|
|
|
Infanrix -IPV/Hib |
| Vaccine Information |
- Vaccine Name: Infanrix -IPV/Hib
- Product Name: Diphtheria, tetanus, pertussis (acellular component), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed)
- Tradename: Infanrix -IPV/Hib
- Manufacturer: GlaxoSmithKline
- Vaccine Ontology ID: VO_0010722
- CDC CVX code: 120
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B Neomycin , Latex in plunger stopper of prefilled syringe
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store in a refrigerator (2°C – 8°C).
- Approved Age for Licensed Use: 2 months to 6 years of age.
- Description: Products: Proteins + killed virus + conjugate. Other components: Formaldehyde Polysorbate 80, Lactose.
|
| References |
|
|
|
Infanrix-hexa |
| Vaccine Information |
- Vaccine Name: Infanrix-hexa
- Product Name: Combined diphtheria and tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis and adsorbed conjugated Haemophilus influenzae type b vaccine
- Tradename: Infanrix-hexa
- Manufacturer: GlaxoSmithKline
- Vaccine Ontology ID: VO_0010719
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B Neomycin, Latex in plunger stopper of prefilled syringe
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Should be stored at 2° to 8°C (35° to 46°F).
- Approved Age for Licensed Use: Under 7 years of age.
- Description: Products: Proteins + killed viruses + conjugate. Other components: Yeast protein Formaldehyde, Lactose, Polysorbate 20 and 80.
|
| References |
|
|
|
Infanrix-hexa |
| Vaccine Information |
- Vaccine Name: Infanrix-hexa
- Product Name: Combined diphtheria and tetanus toxoids, acellular pertussis, hepatitis B (recombinant), inactivated poliomyelitis and adsorbed conjugated Haemophilus influenzae type b vaccine
- Tradename: Infanrix-hexa
- Manufacturer: GlaxoSmithKline
- Vaccine Ontology ID: VO_0010719
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B Neomycin, Latex in plunger stopper of prefilled syringe
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Should be stored at 2° to 8°C (35° to 46°F).
- Approved Age for Licensed Use: Under 7 years of age.
- Description: Products: Proteins + killed viruses + conjugate. Other components: Yeast protein Formaldehyde, Lactose, Polysorbate 20 and 80.
|
| References |
|
|
|
Infanrix-IPV |
| Vaccine Information |
- Vaccine Name: Infanrix-IPV
- Product Name: Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed)
- Tradename: Infanrix-IPV
- Manufacturer: GlaxoSmithKline
- Vaccine Ontology ID: VO_0010721
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B Neomycin , Latex in plunger stopper of prefilled syringes
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store in a refrigerator (2°C - 8°C).
- Approved Age for Licensed Use: 2 months to 6 years of age.
- Description: Products: Proteins + killed virus. Other components: Formaldehyde, Polysorbate 80.
|
| References |
|
|
|
Pediacel |
| Vaccine Information |
- Vaccine Name: Pediacel
- Product Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine and Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate)
- Tradename: Pediacel
- Manufacturer: Sanofi Pasteur Ltd
- Vaccine Ontology ID: VO_0010730
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Neomycin Polymyxin B Streptomycin, Latex in stopper of vial
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2° to 8°C (35° to 46°F).
- Approved Age for Licensed Use: 2 months to 6 years of age.
- Description: Products: Proteins, killed virus + conjugate. Other components: Bovine serum Formaldehyde, Polysorbate 80.
|
| References |
|
|
|
Pediacel |
| Vaccine Information |
- Vaccine Name: Pediacel
- Product Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine and Haemophilus b Conjugate Vaccine (Tetanus Protein – Conjugate)
- Tradename: Pediacel
- Manufacturer: Sanofi Pasteur Ltd
- Vaccine Ontology ID: VO_0010730
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Neomycin Polymyxin B Streptomycin, Latex in stopper of vial
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2° to 8°C (35° to 46°F).
- Approved Age for Licensed Use: 2 months to 6 years of age.
- Description: Products: Proteins, killed virus + conjugate. Other components: Bovine serum Formaldehyde, Polysorbate 80.
|
| References |
|
|
|
Pentacel |
| Vaccine Information |
- Vaccine Name: Pentacel
- Product Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine
- Tradename: Pentacel
- Manufacturer: Sanofi Pasteur Limited
- Vaccine Ontology ID: VO_0000084
- CDC CVX code: 120
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: USA (License #1726), Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B, Neomycin
- Preparation: Corynebacterium diphtheriae is grown in modified Mueller’s growth medium. After purification by ammonium sulfate fractionation, the diphtheria toxin is detoxified with formaldehyde and diafiltered (FDA: Pentacel).
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2° to 8°C (35° to 46°F). Do not freeze.
- Approved Age for Licensed Use: 6 weeks to 4 years of age.
- Contraindication: A severe allergic reaction (e.g., anaphylaxis) after a previous dose of Pentacel vaccine, any ingredient of this vaccine, or any other tetanus toxoid, diphtheria toxoid, pertussis-containing vaccine, inactivated poliovirus vaccine or H influenzae type b vaccine is a contraindication (FDA: Pentacel).
- Description: It consists of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus (DTaP-IPV) component and an ActHIB® vaccine component. Pentacel vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b (FDA: Pentacel).
|
| References |
FDA: Pentacel: FDA: Pentacel [http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172502.htm]
|
|
Pentacel |
| Vaccine Information |
- Vaccine Name: Pentacel
- Product Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine
- Tradename: Pentacel
- Manufacturer: Sanofi Pasteur Ltd
- Vaccine Ontology ID: VO_0000084
- CDC CVX code: 120
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: USA (License #1726), Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B, Neomycin
- Preparation: Corynebacterium diphtheriae is grown in modified Mueller’s growth medium. After purification by ammonium sulfate fractionation, the diphtheria toxin is detoxified with formaldehyde and diafiltered (FDA: Pentacel).
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2° to 8°C (35° to 46°F). Do not freeze.
- Approved Age for Licensed Use: 6 weeks to 4 years of age.
- Contraindication: A severe allergic reaction (e.g., anaphylaxis) after a previous dose of Pentacel vaccine, any ingredient of this vaccine, or any other tetanus toxoid, diphtheria toxoid, pertussis-containing vaccine, inactivated poliovirus vaccine or H influenzae type b vaccine is a contraindication (FDA: Pentacel).
- Description: It consists of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus (DTaP-IPV) component and an ActHIB® vaccine component. Pentacel vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b (FDA: Pentacel).
|
| References |
FDA: Pentacel: FDA: Pentacel [http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm172502.htm]
|
|
Quadracel |
| Vaccine Information |
- Vaccine Name: Quadracel
- Product Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine
- Tradename: Quadracel
- Manufacturer: Sanofi Pasteur Ltd
- Vaccine Ontology ID: VO_0010736
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Polymyxin B, Neomycin
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2 to 8C (35 to 46F). Do not freeze.
- Approved Age for Licensed Use: 2 months to six years of age.
|
| References |
|
|
|
ViVaxim |
| Vaccine Information |
- Vaccine Name: ViVaxim
- Product Name: Combined Purified Vi Polysaccharide Typhoid and Inactivated Hepatitis A Vaccine
- Tradename: ViVaxim
- Manufacturer: Sanofi Pasteur Ltd
- Vaccine Ontology ID: VO_0010748
- Type: Subunit vaccine + Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: Canada
- Host Species for Licensed Use: Human
- Adjuvant:
- Preservative: 2 phenoxy ethanol
- Allergen: Neomycin
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store at 2° to 8°C (35° to 46°F).
- Approved Age for Licensed Use: 16 years of age and older.
- Description: Products: Polysaccharide + killed virus. Other components: Formaldehyde, Polysorbate 80.
|
| References |
|
|
|
